Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Solana CoHSDT · Entity 6630 | Director · President and CEO | April 30, 2020 | May 01, 2020 |
| Z Squared Inc.COEP · Entity 6495 | Director | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Solana Co
Report date April 30, 2020 · Filed May 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 90,858 |
Reported balance
After 2020-04-30 transaction · row 1
1 source rowRow 1 · 2020-04-30 · Grant · Acquired 9,320 · Balance 90,858 F1: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy LLC | 666,911 |
Reported balance
Holding disclosure · report date 2020-04-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 666,911 F3: These securities are directly held by Deschamps Global Healthcare Commercialization LLC (the "LLC") and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are represented by fully vested restricted stock awards (the "RSAs").
F2: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation.
F3: These securities are directly held by Deschamps Global Healthcare Commercialization LLC (the "LLC") and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC.
Z Squared Inc.
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 8,950 |
Reported balance
After 2026-02-11 transaction · row 1
1 source rowRow 1 · 2026-02-11 · Exercise / conversion · Acquired 5,700 · Balance 8,950 F1: Represents the exercise price of shares purchased upon exercise of stock options. |
| Common StockSEC Table I · non-derivative | Direct | 8,950 |
Reported balance
After 2026-02-11 transaction · row 2
1 source rowRow 2 · 2026-02-11 · Grant · Acquired 3,250 · Balance 8,950 F2: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the exercise price of shares purchased upon exercise of stock options.
F2: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 13, 2026 17:00 UTC | Z Squared Inc. COEP · Entity 6495 | GrantCommon Stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001031 · ownership.xml · nonDerivative · entry 2 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:00 UTC | Z Squared Inc. COEP · Entity 6495 | Exercise / conversionCommon stock | 5,700 | $10.56 | $60,192.00 |
DisclosureSEC source: 0001683168-26-001031 · ownership.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. Read SEC document |
| March 04, 2025 Filed Mar 10, 2025 21:23 UTC | Z Squared Inc. COEP · Entity 6495 | GrantNon-qualified Stock Options (right to buy) · Derivative | 5,700 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001475 · ownership.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Underlying: Common Stock · 5,700 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 10:53 UTC | Z Squared Inc. COEP · Entity 6495 | GrantNon-qualified Stock Options (right to buy) · Derivative | 30,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000428 · ownership.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| April 30, 2020 Filed May 1, 2020 15:38 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 9,320 | $0.43 | $4,007.60 |
DisclosureSEC source: 0001209191-20-026455 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,858 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 16:55 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 14,809 | $0.27 | $3,998.43 |
DisclosureSEC source: 0001209191-20-024746 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,538 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| March 31, 2020 Filed Apr 6, 2020 17:04 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 12,117 | $0.33 | $3,998.61 |
DisclosureSEC source: 0001209191-20-023567 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,729 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 23:05 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 8,507 | $0.47 | $3,998.29 |
DisclosureSEC source: 0001209191-20-019389 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,612 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 21:21 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 4,394 | $0.91 | $3,998.54 |
DisclosureSEC source: 0001209191-20-014445 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,105 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 13:16 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 4,704 | $0.85 | $3,998.40 |
DisclosureSEC source: 0001209191-20-009885 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,711 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 12:52 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 3,959 | $1.01 | $3,998.59 |
DisclosureSEC source: 0001209191-20-006177 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,007 F1 · shares: These shares are represented by fully vested restricted stock awards (the "RSAs"). F2 · price: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 12:06 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 3,844 | $1.04 | $3,997.76 |
DisclosureSEC source: 0001209191-20-003789 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,048 F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of the Issuer and are fully vested. F2 · price: The RSUs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSUs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 23:05 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 4,122 | $0.97 | $3,998.34 |
DisclosureSEC source: 0001209191-20-001357 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,204 F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of the Issuer and are fully vested. F2 · price: The RSUs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSUs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 01:01 UTC | Solana Co HSDT · Entity 6630 | GrantClass A Common Stock | 9,087 | $0.44 | $3,998.28 |
DisclosureSEC source: 0001209191-19-060780 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,082 F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of the Issuer and are fully vested. F2 · price: The RSUs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSUs in lieu of a percentage of the Reporting Person's cash compensation. Read SEC document |
| December 07, 2019 Filed Dec 17, 2019 00:57 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001209191-19-060776 · doc4.xml · derivative · entry 2 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Class A Common Stock · 300,000 shares Expires 2026-07-13 F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| December 07, 2019 Filed Dec 17, 2019 00:57 UTC | Solana Co HSDT · Entity 6630 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001209191-19-060776 · doc4.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 300,000 shares Expires 2020-07-13 F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| April 05, 2019 Filed Apr 18, 2019 22:17 UTC | Solana Co HSDT · Entity 6630 | Exercise / conversionWarrant (Right to Buy) · Derivative | 5,018 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0001209191-19-025273 · doc4.xml · derivative · entry 3 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,018 shares Expires 2019-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00=CAD$1.3387 on April 5, 2019. The exercise price of the Warrant was CAD $7.50. Read SEC document |
| April 05, 2019 Filed Apr 18, 2019 22:17 UTC | Solana Co HSDT · Entity 6630 | Exercise / conversionClass A Common Stock | 5,018 | $5.60 | $28,100.80 |
DisclosureSEC source: 0001209191-19-025273 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2019 Filed Apr 2, 2019 01:13 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $6.76 | $0.00 |
DisclosureSEC source: 0001209191-19-022117 · doc4.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Class A Common Stock · 160,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of forty-eight (48) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 15, 2018 Filed May 18, 2018 00:21 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $10.99 | $0.00 |
DisclosureSEC source: 0001209191-18-031237 · doc4.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Class A Common Stock · 95,000 shares Expires 2028-05-15 F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15. F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| December 22, 2017 Filed Dec 26, 2017 22:32 UTC | Solana Co HSDT · Entity 6630 | PurchaseWarrant (Right to Buy) · Derivative | 127,551 | $1.96 Strike: $2.45 | $249,999.96 |
DisclosureSEC source: 0001209191-17-067260 · doc4.xml · derivative · entry 3 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 127,551 Underlying: Class A Common Stock · 127,551 shares Expires 2020-12-22 F2 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96. F4 · derivative.exercise_date: Immediately exercisable. F1 · ownership.nature: These securities were purchased by Deschamps Global Healthcare Commercialization LLC (the "LLC"). The Reporting Person is the sole member of the LLC. Read SEC document |
| December 22, 2017 Filed Dec 26, 2017 22:32 UTC | Solana Co HSDT · Entity 6630 | PurchaseClass A Common Stock | 127,551 | $1.96 | $249,999.96 |
DisclosureSEC source: 0001209191-17-067260 · doc4.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 3,334,556 F1 · shares: These securities were purchased by Deschamps Global Healthcare Commercialization LLC (the "LLC"). The Reporting Person is the sole member of the LLC. F2 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96. F3 · ownership.nature: Represents shares directly held by the LLC and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:03 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000899243-17-010591 · doc4.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Class A Common Stock · 1,000,000 shares Expires 2027-04-17 F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16 F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.